US › Healthcare

Onconetix Inc (ONCO)

US · Healthcare · Biotechnology

$0.83+2.90%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$21,457

Revenue YoY

-78.9%

Net profit

$-4.2M

Profit YoY

+50.7%

EPS

$0.00

EPS estimate

$0.00

Net margin

-19,643.4%

Key statistics

Market cap

$3.1M

P/E

0.0

Forward P/E

0.0

P/B

0.26

Book value

$42.63

EPS (TTM)

$1,377.40

52-week high

$209.50

52-week low

$0.67

50-day MA

$0.99

200-day MA

$53.70

Beta

2.68

Analyst view

Analysts rate Onconetix Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $9.00.

Shareholding

Insiders

0.17%

Institutions

5.73%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.10%
Citigroup Inc	0.01%
UBS Group AG	0.01%
Tower Research Capital LLC	0.01%
SBI Securities Co Ltd	0.00%
DRW Securities, LLC	0.00%
Danske Bank A/S.	0.00%
XTX Topco Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Onconetix Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.